New drug shows promise for rare autoimmune disease
Disease control
Terminated
This study tested a drug called zanubrutinib in 6 adults with neuromyelitis optica spectrum disorder (NMOSD), a rare disease where the immune system attacks the nerves in the eyes and spine. The goal was to see if the drug could prevent relapses and reduce disability. The trial w…
Phase: PHASE2 • Sponsor: Xuanwu Hospital, Beijing • Aim: Disease control
Last updated May 07, 2026 18:43 UTC